PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon Research Solutions, Inc. and Virtify, Inc. Announce Strategic Partnership - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc. a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced a strategic partnership with Virtify, Inc. of Cambridge, MA.
Octagon Research Solutions, Inc. and Virtify, Inc. Announce Strategic Partnership

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2006/05/15 - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc. a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced a strategic partnership with Virtify, Inc. of Cambridge, MA..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

– CEO & Chairman Jim Walker of Octagon Research Solutions, Inc. a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced a strategic partnership with Virtify, Inc. of Cambridge, MA, a premium provider of information technology related products and solutions to the Life Sciences market. This new marketing partnership and venture will enable Octagon and Virtify to pair domain expertise with innovative technology solutions for the life sciences industry.

This marketing partnership is based on the concept that technology and domain expertise are codependent forces that are essential to the development of breakthrough improvements in research and development processes. Satish Tadikonda, President of Virtify noted, “Virtify’s product portfolio continues to expand to address the changing needs of the life sciences industry, especially in the clinical, regulatory and commercialization areas. Our partnership with Octagon will enable us to broaden our reach and secure market share in a complex and evolving marketplace.”

Jim Walker, Chairman and CEO of Octagon added, “We are very excited about the new partnership with Virtify. We are already using Virtify’s virtx:spl Global Labeling Solution to facilitate our SPL conversion service, and have developed a strong partnership that extends to global labeling initiatives and the capabilities required to support them. We are looking forward to a very successful partnership with Virtify.”

Joint marketing activities included in the partnership consist of educational programs, webinars and other promotional opportunities currently being developed under the partnership arrangement. These activities are expected to address a continuing need for education and broader understanding of emerging standards such as Regulated Product Submissions and regulations such as the Physicians Labeling Rule.

About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK.

About Virtify, Inc.
Virtify is a premium provider of information technology related products and solutions to the Life Sciences market. Virtify’s product portfolio includes products to support the clinical and regulatory activities at Life Sciences companies. Virtify also develops high-quality custom information technology solutions for its clients helping them improve their product and project management processes. These products and solutions help its clients accelerate their decision-making process and greatly reduce time-to-market. Virtify's product portfolio includes the Global Labeling Solution and the Virtify Investigator Database, a tool to help companies manage clinical trials efficiently. An example of a solution is an ongoing engagement with a multinational pharmaceutical company where Virtify is developing and implementing a web-based enterprise, 21 CFR Part 11 compliant, electronic-records management system that allows authorized users to track and manage key regulatory information and milestones. Virtify is headquartered in Cambridge, MA and has other international development and product support centers.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. and Virtify, Inc. Announce Strategic Partnership

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Graham 
610 535 6500 ext 5655 jgraham[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)